Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

BUY
$7.46 - $14.14 $1.65 Million - $3.13 Million
221,700 Added 30.22%
955,400 $9.32 Million
Q4 2021

Feb 15, 2022

SELL
$12.99 - $17.73 $5.7 Million - $7.78 Million
-438,600 Reduced 37.41%
733,700 $10.5 Million
Q3 2021

Nov 16, 2021

BUY
$14.85 - $21.34 $10.6 Million - $15.3 Million
715,100 Added 156.41%
1,172,300 $23.5 Million
Q2 2021

Aug 16, 2021

BUY
$20.19 - $34.17 $9.07 Million - $15.3 Million
449,200 Added 5615.0%
457,200 $10.1 Million
Q1 2021

May 18, 2021

BUY
$23.29 - $53.2 $186,320 - $425,600
8,000 New
8,000 $272,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.